Cytokeratin 5/6 Immunohistochemical Expression

Known as: CK5/6, CK 5/6 Immunohistochemical Expression, CK 5/6 Expression 
An immunohistochemical diagnostic test utilizing an antibody to detect both cytokeratin 5 and 6 in tissues.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2017
05019902017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Immunohistochemistry is increasingly utilized to differentiate lung adenocarcinoma and squamous cell carcinoma. However, detailed… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
The availability of targeted therapies has created a need for precise subtyping of non-small cell lung carcinomas (NSCLCs). The… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The molecular classification for breast carcinomas has been used in clinical studies with a simple surrogate panel of… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Triple-negative breast cancer (estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) is a… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Basal-like breast cancer has been extensively characterized on the basis of gene expression profiles, but it is becoming… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Tumours arising in BRCA1 mutation carriers and sporadic basal-like breast carcinomas have similar phenotypic, immunohistochemical… (More)
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
A better molecular characterization of breast cell lines (BCL) may help discover new markers to apply to tumour samples. We… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Brain metastases (BM) from breast cancer are associated with significant morbidity and mortality. In the current study, we have… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Breast cancer is recognised to be a heterogeneous disease with a range of morphological appearances and behaviours… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE To investigate the proportion of breast cancers arising in patients with germ line BRCA1 and BRCA2 mutations expressing… (More)
  • table 1
  • table 3
  • table 2
  • table 4
Is this relevant?